Get the Stockscreener App
3.16
0.32%
0.01
Theratechnologies Inc stock is traded at $3.16, with a volume of 709.74K.
It is up +0.32% in the last 24 hours and up +37.39% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$3.15
Open:
$3.16
24h Volume:
709.74K
Relative Volume:
1.51
Market Cap:
$145.30M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-63.20
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
-0.32%
1M Performance:
+37.39%
6M Performance:
+119.44%
1Y Performance:
+124.11%
1-Day Range:
$3.15
$3.16
1-Week Range:
$3.15
$3.17
52-Week Range:
$1.12
$3.20
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
3.16 | 144.84M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
Why is Theratechnologies Inc. stock attracting strong analyst attentionPre Market Ideas For Beginners - jammulinksnews.com
Objective long/short (TH) Report (TH:CA) - news.stocktradersdaily.com
Published on: 2025-07-29 11:47:54 - metal.it
What catalysts could drive Theratechnologies Inc. stock higher in 2025Unlock powerful market trend analysis - jammulinksnews.com
Is it the right time to buy Theratechnologies Inc. stockBuild wealth faster with disciplined trading - jammulinksnews.com
Does Theratechnologies Inc. stock perform well during market downturnsAchieve consistent profits with proven methods - jammulinksnews.com
How volatile is Theratechnologies Inc. stock compared to the marketAchieve rapid portfolio growth with expert help - jammulinksnews.com
What is the dividend policy of Theratechnologies Inc. stockUnlock steady growth with low-risk stocks - jammulinksnews.com
Why Theratechnologies Inc. stock attracts strong analyst attention200 Percent Profit Outlook - metal.it
What is Theratechnologies Inc. company’s growth strategyUnmatched profit growth - jammulinksnews.com
How Theratechnologies Inc. stock performs during market volatilityInsider Strategy Insight - metal.it
Is Theratechnologies Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia
Will Theratechnologies Inc. stock benefit from interest rate changesHigh-impact stock picks - jammulinksnews.com
Theratechnologies Inc. Stock Analysis and ForecastHigh-yield trading alerts - PrintWeekIndia
How high can Theratechnologies Inc. stock price go in 2025Free Investment Risk Control - jammulinksnews.com
Is Theratechnologies Inc. stock overhyped or has real potentialSuperior risk-adjusted returns - jammulinksnews.com
(TH) Proactive Strategies (TH:CA) - news.stocktradersdaily.com
What drives Theratechnologies Inc. stock priceTremendous growth opportunities - Autocar Professional
What analysts say about Theratechnologies Inc. stockDouble-digit growth - jammulinksnews.com
How to Take Advantage of moves in (TH) (TH:CA) - news.stocktradersdaily.com
Theratechnologies to Hold Special Shareholder Meeting in September 2025 - AInvest
Theratechnologies Reports Financial Results for the Second Quarter 2025 - ADVFN Brasil
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):